Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaohong Xue
Observed names:
Xue Xiaohong,
Xue, Xiaohong
Institutions:
Shanghai University of Traditional Chinese Medicine,
Yueyang Hospital
Observed institutions:
National Natural Science Foundation of China,
Shanghai University of Traditional Chinese Medicine,
Yueyang Hospital
ORCID:
0000-0001-5630-8731
Observed ORCID:
0000-0001-5630-8731
OpenAlex ID:
A5100732659
Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer
2019
·
Jiayu Sheng
, Xiaohong Xue
, et al.
·
Current Molecular Medicine
·
20
The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study
2021
·
Yajie Ji
, Siyu Li
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
18
PDF
The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial
2020
·
Yajie Ji
, Siyu Li
, et al.
·
Trials
·
18
PDF
Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study
2026
·
Wei Luo
, Yan Dai
, et al.
·
Frontiers in Oncology
·
2
PDF
CD14 macrophage and IL-10 levels in the peripheral blood of breast cancer patients and their diagnostic value*
2022
·
Mengting Dong
, Jiayu Sheng
, et al.
·
Oncology and Translational Medicine
·
1
Prolactin-Linked Plasma Cell–Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center Prediction Study with Tissue Correspondence
2026
·
Weili Chen
, Mengting Li
, et al.
·
International Journal of Women s Health
Construction and validation of a prognostic model for seroma after breast cancer surgery: a dual-center retrospective cohort study
2026
·
Zongxin Chen
, Qian Zhou
, et al.
·
Frontiers in Oncology
PDF
LncRNA TAT-AS1 promotes the progression of breast cancer through the hsa-miR-3187-5p/RUNX1 axis and its clinical value
2026
·
Yu Liu
, Deyu Fu
, et al.
·
European journal of medical research
MRI Radiomics and MAGIC Technology in Breast Cancer NAC Response Assessment
2025
·
Chao Gao
, Xiaohong Xue
·
Academic Radiology
Treatment of Plasma Cell Mastitis by Integrated Traditional Chinese and Western Medicine:a Meta-analysis
2018
·
Xia Yalin
, Siyu Li
, et al.
Research Progress on Leukopenia after Breast Cancer Chemotherapy by Chinese Medicine
2013
·
Xiaohong Xue
·
Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai
Application of color Doppler ultrasound in triple negative breast cancer
2013
·
Xiaohong Xue
·
Journal of Bengbu Medical College
Diagnostic value of fiberopticductoscopy and galactography in T_0-stage breast cancer with nipple discharge
2013
·
Xiaohong Xue
·
Zhonghua zhongliu fangzhi zazhi
Show more works
View as search
Works count:
16
Citation count:
59
H-index:
3
I10-index:
3
Year
Topic
Type